S&P 500   3,577.59 (+0.56%)
DOW   29,591.27 (+1.12%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
S&P 500   3,577.59 (+0.56%)
DOW   29,591.27 (+1.12%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
S&P 500   3,577.59 (+0.56%)
DOW   29,591.27 (+1.12%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
S&P 500   3,577.59 (+0.56%)
DOW   29,591.27 (+1.12%)
QQQ   290.39 (+0.00%)
AAPL   113.85 (-2.97%)
MSFT   210.11 (-0.13%)
FB   268.43 (-0.47%)
GOOGL   1,727.56 (-0.51%)
AMZN   3,098.39 (-0.03%)
TSLA   521.85 (+6.58%)
NVDA   525.60 (+0.40%)
BABA   270.11 (-0.23%)
CGC   24.72 (+4.22%)
GE   10.07 (+3.18%)
MU   64.18 (+4.53%)
AMD   85.31 (+0.79%)
T   28.62 (+1.06%)
NIO   55.38 (+12.45%)
F   8.86 (+1.37%)
ACB   7.18 (+0.70%)
GILD   59.89 (-0.37%)
NFLX   476.62 (-2.38%)
BA   211.53 (+5.97%)
DIS   145.98 (+3.48%)
Log in
OTCMKTS:MHTX

Manhattan Scientifics Stock Forecast, Price & News

$0.03
0.00 (-6.14 %)
(As of 11/23/2020 03:57 PM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03▼
$0.03
50-Day Range
$0.01
MA: $0.02▼
$0.03
52-Week Range
$0.01
Now: $0.03▼
$0.03
Volume621,426 shs
Average Volume278,710 shs
Market Capitalization$15.34 million
P/E RatioN/A
Dividend YieldN/A
Beta1.76
Manhattan Scientifics, Inc., a technology incubator, develops and commercializes life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.50 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolOTCMKTS:MHTX
Previous Symbol
CUSIPN/A
CIK1099132
Webwww.mhtx.com
Phone212-541-2405
Employees1

Debt

Debt-to-Equity RatioN/A
Current Ratio0.35
Quick Ratio0.35

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$100,000.00
Price / Sales153.39
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-1,220,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-3.59%

Miscellaneous

Outstanding Shares557,781,000
Market Cap$15.34 million
Next Earnings Date11/25/2020 (Estimated)
OptionableNot Optionable
$0.03
0.00 (-6.14 %)
(As of 11/23/2020 03:57 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MHTX News and Ratings via Email

Sign-up to receive the latest news and ratings for MHTX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Manhattan Scientifics (OTCMKTS:MHTX) Frequently Asked Questions

How has Manhattan Scientifics' stock been impacted by Coronavirus?

Manhattan Scientifics' stock was trading at $0.0133 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MHTX shares have increased by 106.8% and is now trading at $0.0275.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Manhattan Scientifics?

Wall Street analysts have given Manhattan Scientifics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Manhattan Scientifics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Manhattan Scientifics' next earnings date?

Manhattan Scientifics is scheduled to release its next quarterly earnings announcement on Wednesday, November 25th 2020.
View our earnings forecast for Manhattan Scientifics.

How were Manhattan Scientifics' earnings last quarter?

Manhattan Scientifics, Inc. (OTCMKTS:MHTX) posted its quarterly earnings data on Monday, August, 20th. The technology company reported $0.00 EPS for the quarter.
View Manhattan Scientifics' earnings history.

Are investors shorting Manhattan Scientifics?

Manhattan Scientifics saw a increase in short interest in October. As of October 15th, there was short interest totaling 34,400 shares, an increase of 72.0% from the September 30th total of 20,000 shares. Based on an average daily trading volume, of 1,913,100 shares, the short-interest ratio is presently 0.0 days.
View Manhattan Scientifics' Short Interest.

Who are some of Manhattan Scientifics' key competitors?

Some companies that are related to Manhattan Scientifics include Evans & Sutherland Computer (ESCC), Environmental Tectonics (ETCC), mPhase Technologies (XDSL), Isomet (IOMT), AER Energy Resources (AERN), Axion Power International (AXPWQ), Hoku (HOKUQ), Lightscape Technologies (LTSC), Millennium Cell (MCELQ), Oakridge Global Energy Solutions (OGES), RoboGroup T.E.K. (ROBOF) and Wireless Xcessories Group (WIRX).
View all competitors.

What other stocks do shareholders of Manhattan Scientifics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Scientifics investors own include Sierra Wireless, Inc. (SW.TO) (SW), Advanced Micro Devices (AMD), InterCloud Systems (ICLD), Inpixon (INPX), PositiveID (PSID), ARCA biopharma (ABIO), Acorn Energy (ACFN), Aware (AWRE), Alexco Resource (AXU) and Biocept (BIOC).

Who are Manhattan Scientifics' key executives?

Manhattan Scientifics' management team includes the following people:
  • Mr. Marvin Maslow, Chairman (Age 82)
  • Mr. Emmanuel Tsoupanarias, Pres, CEO & Director (Age 67, Pay $186k)
  • Mr. Leonard C. Friedman, Sec. (Age 82)
  • Mr. Robert Romeo Proulx, Pres of Imagion (Age 62)

What is Manhattan Scientifics' stock symbol?

Manhattan Scientifics trades on the OTCMKTS under the ticker symbol "MHTX."

How do I buy shares of Manhattan Scientifics?

Shares of MHTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Manhattan Scientifics' stock price today?

One share of MHTX stock can currently be purchased for approximately $0.03.

How big of a company is Manhattan Scientifics?

Manhattan Scientifics has a market capitalization of $15.34 million and generates $100,000.00 in revenue each year. Manhattan Scientifics employs 1 workers across the globe.

What is Manhattan Scientifics' official website?

The official website for Manhattan Scientifics is www.mhtx.com.

How can I contact Manhattan Scientifics?

Manhattan Scientifics' mailing address is 244 Fifth Ave Suite 2341, New York NY, 10001. The technology company can be reached via phone at 212-541-2405 or via email at [email protected]

This page was last updated on 11/23/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.